Zhejiang Conba Pharmaceutical Co., Ltd. Class ASSE: 600572

"Zhejiang CONBA Pharmaceutical Co., Ltd."Announcement on the Execution of the License, Development and Commercialization Agreement for Cebranopadol in Greater China by Subsidiaries Hangzhou CONBA and Hong Kong CONBA with Adneuris

· Issued by Zhejiang Conba Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on the Execution of the License, Development and Commercialization Agreement for Cebranopadol in Greater China by Subsidiaries Hangzhou CONBA and Hong Kong CONBA with Adneuris

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Zhejiang Conba Pharmaceutical Co., Ltd. Class A

All Zhejiang Conba Pharmaceutical Co., Ltd. Class A news releases